CN105769786A - 一种米拉贝隆缓释片及其制备方法 - Google Patents
一种米拉贝隆缓释片及其制备方法 Download PDFInfo
- Publication number
- CN105769786A CN105769786A CN201410837267.6A CN201410837267A CN105769786A CN 105769786 A CN105769786 A CN 105769786A CN 201410837267 A CN201410837267 A CN 201410837267A CN 105769786 A CN105769786 A CN 105769786A
- Authority
- CN
- China
- Prior art keywords
- sustained
- merariveron
- release tablet
- mirabegron
- release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
处方 | 重量百分配比 |
米拉贝隆 | 0.5%-30% |
水溶性聚合物材料 | 10%-50% |
稀释剂 | 30%-50% |
助溶剂 | 2%-10% |
助流剂 | 0.5%-1% |
润滑剂 | 0.5%-1% |
缓释包衣材料 | 5%-20% |
增塑剂 | 0.5%-2% |
抗粘剂 | 5%-20% |
总计 | 100% |
配方 | 量(g) |
米拉贝隆 | 180 |
羟丙基甲基纤维素E6 | 70 |
微晶纤维素 | 210 |
十二烷基硫酸钠 | 30 |
二氧化硅 | 6 |
硬脂酸镁 | 6 |
聚丙烯酸树脂NE30D(30%水分散体) | 110 |
柠檬酸三乙酯 | 12 |
滑石粉 | 62 |
总计 | 686 |
配方 | 量(g) |
米拉贝隆 | 240 |
羟丙纤维素 | 200 |
乳糖 | 250 |
维他命E TPGS | 30 |
二氧化硅 | 6 |
硬脂酸镁 | 6 |
乙基纤维素水分散体(30%) | 100 |
柠檬酸三乙酯 | 10 |
滑石粉 | 58 |
总计 | 900 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410837267.6A CN105769786B (zh) | 2014-12-24 | 2014-12-24 | 一种米拉贝隆缓释片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410837267.6A CN105769786B (zh) | 2014-12-24 | 2014-12-24 | 一种米拉贝隆缓释片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105769786A true CN105769786A (zh) | 2016-07-20 |
CN105769786B CN105769786B (zh) | 2019-04-26 |
Family
ID=56389663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410837267.6A Active CN105769786B (zh) | 2014-12-24 | 2014-12-24 | 一种米拉贝隆缓释片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105769786B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018108939A3 (de) * | 2016-12-13 | 2018-08-16 | Stada Arzneimittel Ag | Feste pharmazeutische orale darreichungsform mit verlängerter wirkstofffreisetzung umfassend mirabegron |
CN109806236A (zh) * | 2017-11-21 | 2019-05-28 | 江苏神龙药业股份有限公司 | 一种米拉贝隆组合物及其制备方法 |
CN114617881A (zh) * | 2022-02-19 | 2022-06-14 | 苏州海景医药科技有限公司 | 一种米拉贝隆组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991552A (zh) * | 2009-09-25 | 2011-03-30 | 宋洪涛 | 他克莫司缓控释制剂及制备方法 |
CN103655503A (zh) * | 2013-11-25 | 2014-03-26 | 北京润德康医药技术有限公司 | 一种米拉贝隆缓释片及其制备方法 |
-
2014
- 2014-12-24 CN CN201410837267.6A patent/CN105769786B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991552A (zh) * | 2009-09-25 | 2011-03-30 | 宋洪涛 | 他克莫司缓控释制剂及制备方法 |
CN103655503A (zh) * | 2013-11-25 | 2014-03-26 | 北京润德康医药技术有限公司 | 一种米拉贝隆缓释片及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018108939A3 (de) * | 2016-12-13 | 2018-08-16 | Stada Arzneimittel Ag | Feste pharmazeutische orale darreichungsform mit verlängerter wirkstofffreisetzung umfassend mirabegron |
CN109806236A (zh) * | 2017-11-21 | 2019-05-28 | 江苏神龙药业股份有限公司 | 一种米拉贝隆组合物及其制备方法 |
CN114617881A (zh) * | 2022-02-19 | 2022-06-14 | 苏州海景医药科技有限公司 | 一种米拉贝隆组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN105769786B (zh) | 2019-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5582701B2 (ja) | 被覆医薬製剤およびポリマー混合被覆した医薬製剤の製造のためのポリマー混合物の使用 | |
CN101987091B (zh) | 盐酸文拉法辛缓释微丸胶囊 | |
EP1748764B1 (en) | An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production | |
EP3498264B1 (en) | Pharmaceutical preparation for oral administration with controlled dissolution rate, the preparation comprising tamsulosin hydrochloride-containing sustained-release pellets | |
CN1384739A (zh) | 缓释的口服药物形式 | |
CN107260700A (zh) | 一种替格瑞洛复方口服固体制剂的制备方法 | |
EP2754438B2 (en) | Coating composition, drug-containing particle, solid preparation and method for preparing drug-containing particle | |
CN105769786A (zh) | 一种米拉贝隆缓释片及其制备方法 | |
CN101862305B (zh) | 一种盐酸氨溴索缓释微丸及制备方法 | |
CN102058544B (zh) | 非诺贝特酸胆碱盐肠溶缓释微丸的制备方法 | |
CN105769773B (zh) | 洛索洛芬钠缓释微丸 | |
EP2001444A2 (en) | Coated formulations for tolterodine | |
CN105055350B (zh) | 一种含有质子泵抑制剂的片剂的制备方法 | |
CN101411702B (zh) | 盐酸奈福泮萘普生钠复方缓释制剂及其制备方法 | |
CN111135153A (zh) | 一种熊去氧胆酸胶囊及其制备方法 | |
WO2019237446A1 (zh) | 一种曲美他嗪缓释片及其制备方法 | |
CN105687158B (zh) | 一种时间依赖释放机制的美沙拉嗪微粒制剂及其制备方法 | |
CN101933913A (zh) | 一种盐酸右哌甲酯双释放制剂及其制备方法 | |
EP3892263A1 (en) | Oral dosage form | |
CN104116715A (zh) | 一种高载药量的奥卡西平缓释颗粒剂及其制备方法 | |
US20180235913A1 (en) | An oral pharmaceutical formulation comprising sustained-release granules containing tamsulosin hydrochloride | |
CN109833299B (zh) | 一种微粉化罗沙替丁醋酸酯药用盐微丸及其制备方法和其应用 | |
CN109833306B (zh) | 一种罗沙替丁醋酸酯药用盐缓释微丸及其制备方法和其应用 | |
EP3881832A1 (en) | Pharmaceutical composition containing tamsulosin hydrochloride with excellent acid resistance and preparation method therefor | |
CN114209668B (zh) | 一种盐酸阿夫唑嗪缓释制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 201210 Shanghai Pudong New Area China (Shanghai) free trade test area No. 1999 Zhang Heng Road No. 7 Applicant after: Shanghai Double Star Thai Pharmaceutical Technology Co., Ltd. Address before: 201203 Shanghai city Pudong New Area Bing Road No. 306 building 3 floor No. 1 Applicant before: SHANGHAI SUNTECH PHARMACEUTICAL CO., LTD. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210416 Address after: 201210 building 7, 1999 zhangheng Road, Pudong New Area, Shanghai Patentee after: SHANGHAI FOSUN XINGTAI PHARMA TECHNOLOGY Co.,Ltd. Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP Co.,Ltd. Address before: 201210 Shanghai Pudong New Area China (Shanghai) free trade test area No. 1999 Zhang Heng Road No. 7 Patentee before: SHANGHAI FOSUN XINGTAI PHARMA TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |